Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice
Abstract High mobility group box 1 (HMGB1) is a nuclear DNA binding protein that acts as an alarmin when secreted. HMGB1 is increased in systemic lupus erythematosus and might represent a potential therapeutic target. We investigated whether treatment with an anti-HMGB1 antibody affects the developm...
Saved in:
Main Authors: | Fleur Schaper (Author), Mirjan M van Timmeren (Author), Arjen Petersen (Author), Gerda Horst (Author), Marc Bijl (Author), Pieter C Limburg (Author), Johanna Westra (Author), Peter Heeringa (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice
by: Ruxuan Wang, et al.
Published: (2022) -
MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice
by: Yuan Xia, et al.
Published: (2018) -
Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice
by: Hongfeng Zhang, et al.
Published: (2018) -
A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone Mice
by: Nicolas Schall, et al.
Published: (2021) -
Metabolic Profiling Reveals an Abnormal Pattern of Serum Fatty Acids in MRL/lpr Mice Under Treatment With Prednisone
by: Qianqian Li, et al.
Published: (2020)